N@N

AngioDynamics to Present at the Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference

^{Published on 2010-11-30 03:41:09 - Market Wire}
 

ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference, to be held December 7-8, 2010, at the Nikko Hotel in San Francisco.

On Tuesday, December 7, at 2:30 p.m. PT, AngioDynamicsa™ President and Chief Executive Officer Jan Keltjens will review the Companya™s business strategy and recent corporate developments.

To access the webcast during or after the event, please visit the investor relations portion of the Companya™s website at: [ http://investors.angiodynamics.com ]. The replay will be available for 15 days after the event.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].